全文获取类型
收费全文 | 8584篇 |
免费 | 764篇 |
国内免费 | 437篇 |
学科分类
医药卫生 | 9785篇 |
出版年
2024年 | 30篇 |
2023年 | 127篇 |
2022年 | 294篇 |
2021年 | 386篇 |
2020年 | 311篇 |
2019年 | 277篇 |
2018年 | 283篇 |
2017年 | 289篇 |
2016年 | 259篇 |
2015年 | 351篇 |
2014年 | 415篇 |
2013年 | 438篇 |
2012年 | 482篇 |
2011年 | 462篇 |
2010年 | 414篇 |
2009年 | 338篇 |
2008年 | 398篇 |
2007年 | 422篇 |
2006年 | 349篇 |
2005年 | 330篇 |
2004年 | 301篇 |
2003年 | 319篇 |
2002年 | 254篇 |
2001年 | 239篇 |
2000年 | 141篇 |
1999年 | 133篇 |
1998年 | 189篇 |
1997年 | 230篇 |
1996年 | 184篇 |
1995年 | 150篇 |
1994年 | 158篇 |
1993年 | 125篇 |
1992年 | 54篇 |
1991年 | 57篇 |
1990年 | 66篇 |
1989年 | 74篇 |
1988年 | 63篇 |
1987年 | 60篇 |
1986年 | 63篇 |
1985年 | 54篇 |
1984年 | 33篇 |
1983年 | 22篇 |
1982年 | 26篇 |
1981年 | 33篇 |
1980年 | 26篇 |
1979年 | 5篇 |
1978年 | 8篇 |
1977年 | 18篇 |
1976年 | 25篇 |
1975年 | 15篇 |
排序方式: 共有9785条查询结果,搜索用时 15 毫秒
1.
JM Martín† L Calduch† C Monteagudo‡ I Molina† D Ramón† V Alonso† E Jordᆠ《Journal of the European Academy of Dermatology and Venereology》2006,20(4):428-431
Cutaneous plasmacytosis is a rare disorder characterized by a benign proliferation of mature plasma cells that appears as multiple dark-brown to purplish skin lesions, often associated with polyclonal hypergammaglobulinaemia. We present the case of a 55-year-old Caucasian man who suffered from a cutaneous plasmacytosis associated with two different carcinomas. Cutaneous plasmacytosis seems to be a reactive process because most cases reported are not associated with any apparent underlying disease. Nevertheless, because few reported cases were associated with malignancies, screening of additional neoplasms would be justified. 相似文献
2.
发挥远程教育优势推进医学继续教育发展 总被引:9,自引:0,他引:9
《教育部关于加强高校网络教育学院管理提高教学质量的若干意见》中强调指出:高校网络教育学院要以在职人员的继续教育为主,要充分发挥网络教育的优势,为在职人员更新知识、增强技能、不断学习、不断提高提供良好的服务。然而,要使医学院校在开展继续教育中发挥更大的作用,推进医学继续教育的发展,远程教育不仅是解决这一问题的有效途径,而且将成为开展医学继续教育的强大动力。 相似文献
3.
Margaret J Bowers Nick J Orr Si Dempsey H Denis Alexander 《Blood coagulation & fibrinolysis》2006,17(5):409-411
We present a case of Bernard Soulier syndrome in a 9-year-old boy caused by a novel genetic mutation. This child was shown to be homozygous for a single nucleotide deletion (c.1077delG) in the GP1BA gene not previously reported. Clinically, the boy has become refractory to platelet transfusions with both allo-antibodies and iso-antibodies and a massive transfusion requirement for ongoing haemorrhage. We describe the critical role that the blood product transfusion continues to play in the management of Bernard Soulier syndrome and discuss therapeutic options in these patients. 相似文献
4.
JM Vilanova J Figueras-Aloy J Roselló G Gómez E Gelpí R Jiménez 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(5):588-592
The aim of this study was to evaluate the cerebral synthesis of eicosanoids in the asphyctic newborn and to investigate the relation between the prostanoid profiles in cerebrospinal fluid (CSF) and the appearance and severity of hypoxic-ischaemic encephalopathy (HIE). Levels of 6-keto-PGF 1-α, TXB2 , PGE2 and PGF2-α in CSF were measured in 40 full term newborns during the first day of life. Thirty of these newborns had birth asphyxia and were divided into three groups: 10 without HIE, 12 with mild HIE and 8 with moderate-severe HIE. They were compared to a control group of 10 non-hypoxic newborns. Determinations of the metabolites in CSF were performed by RIA and expressed as pg/ml (mean ± SD). The CSF TXB2 (thromboxane A2 metabolite) in asphyxiated newborns was always higher than in the control group (28.12 ± 10.6), and related to the severity of HIE ( p = 0:005): without HIE (50.84 ± 16.4; p = 0:02), mild HIE (80.65 ± 12.64; p ± 0:01) and moderate-severe HIE (178.14 ± 20.5; p < 0:01). The CSF 6-keto-PGF 1-α (prostacyclin metabolite) in asphyxiated newborns was always higher than in the control group (80.55 ± 12.56), but indirectly related to the severity of HIE: without HIE (240.95 ± 28.12; p < 0:01), mild HIE (183.65 ± 30.1; p < 0:01) and moderate-severe HIE (140.55 ± 25.12; p < 0:01). In the moderate-severe HIE group, the increase in TXB2 was higher than the rise in 6-keto-PGF 1-α . 相似文献
5.
6.
7.
Si Young Song 《Taehan Sohwagi Hakhoe chi》2007,49(5):271-279
Cancer is one of the leading causes of death in human, and among various cancers, gastrointestinal cancers occupy more than 55%. Gastric cancer is the first leading cause of cancer-related mortality in the world and the number of pancreas and colon cancers are increasing remarkably during last two decades which will continue to increase in the future. Even though the clinical importance of gastrointestinal cancers is very high and endless efforts has been made to develop novel diagnostic and therapeutic methods to improve the patient's quality of life and survival, the realistic advance in the actual survival benefit of the cancer patients are still strongly required. Nanotechnology has the power to radically change the way of cancer diagnosis and treatment. Currently, there is a lot of researches on novel nanodevices capable of detecting cancer at its earliest stage, pinpointing its location within the body, and delivering anticancer drugs specifically to the malignant cells. Nanoscale devices can readily interact with biomolecules both on the cell surface and within the cell. In addition, nanoscale devices are already proven that they can deliver therapeutic agents to target cells even within specific organelles. Major areas in which nanomedicine is being developed in cancer include early detection and proteomics, imaging diagnostics and multifunctional therapeutics. Because nanotechnology would provide a technical power and tool that enable new diagnostics, therapeutics, and preventives to keep pace with today's explosion in knowledge in the future, it would be very useful to know the perspectives in the direction of nanotechnology as a major clinician responsible for the patients with gastrointestinal malignancies. 相似文献
8.
9.
10.